We are live on ! Find out more
Parallax Volatility Advisers

Parallax Volatility Advisers Portfolio holdings

AUM $58.9B
1-Year Est. Return 51.73%
This Fund
S&P 500
This Quarter Est. Return
+7.66%
1 Year Est. Return
+51.73%
3 Year Est. Return
+168.58%
5 Year Est. Return
+213.54%
10 Year Est. Return
+865.31%
AUM
$73.6B
AUM Growth
+$13B
Cap. Flow
+$743M
Cap. Flow %
1.01%
Top 10 Hldgs %
62.59%
Holding
5,549
New
2,351
Increased
689
Reduced
564
Closed
493

Sector Composition

Rank Sector Weight
1 Miscellaneous 95.88%
2 Financials 0.85%
3 Technology 0.73%
4 Consumer Discretionary 0.62%
5 Industrials 0.44%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GTHX
3626
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
$23K ﹤0.01%
+1,176
New +$25.3K
VBIV
3627
DELISTED
VBI Vaccines, Inc. New Common Stock (Canada)
VBIV
$23K ﹤0.01%
+176
New +$21.6K
NSTG
3628
DELISTED
NanoString Technologies, Inc.
NSTG
$23K ﹤0.01%
+3,108
New +$29.5K
TCFC
3629
DELISTED
The Community Financial Corporation Common Stock
TCFC
$23K ﹤0.01%
+588
New +$21.6K
PMBC
3630
DELISTED
Pacific Mercantile Bancorp
PMBC
$23K ﹤0.01%
+2,646
New +$24.3K
TLGT
3631
DELISTED
Teligent, Inc
TLGT
$23K ﹤0.01%
+622
New +$29.8K
HOME
3632
DELISTED
At Home Group Inc.
HOME
$23K ﹤0.01%
+756
New +$18.4K
MLNT
3633
DELISTED
Melinta Therapeutics, Inc. Common Stock
MLNT
$23K ﹤0.01%
+294
New +$21.8K
AMBR
3634
DELISTED
Amber Road Inc
AMBR
$23K ﹤0.01%
+3,108
New +$23.2K
CHMG icon
3635
Chemung Financial Corp
CHMG
$405M
$22K ﹤0.01%
+462
New +$22.2K
CLSD
3636
DELISTED
Clearside Biomedical
CLSD
$22K ﹤0.01%
+207
New +$22.2K
EML icon
3637
Eastern Company
EML
$151M
$22K ﹤0.01%
+840
New +$23.8K
ESSA
3638
DELISTED
ESSA Bancorp
ESSA
$22K ﹤0.01%
+1,386
New +$21.9K
EVI icon
3639
EVI Industries
EVI
$196M
$22K ﹤0.01%
+546
New +$15.6K
FONR
3640
DELISTED
Fonar
FONR
$22K ﹤0.01%
+924
New +$25.5K
GENC icon
3641
Gencor Industries
GENC
$275M
$22K ﹤0.01%
+1,302
New +$22.8K
MBIN icon
3642
Merchants Bancorp
MBIN
$2.41B
$22K ﹤0.01%
+1,701
New +$21.2K
PEBK icon
3643
Peoples Bancorp of North Carolina
PEBK
$231M
$22K ﹤0.01%
+714
New +$22.4K
TRGP icon
3644
Targa Resources
TRGP
$62.5B
$22K ﹤0.01%
445
+389
+695% +$17.4K
UBFO
3645
DELISTED
United Security Bancshares
UBFO
$22K ﹤0.01%
+1,974
New +$19.5K
HALL
3646
DELISTED
Hallmark Financial Services, Inc.
HALL
$22K ﹤0.01%
+210
New +$23.3K
ZYNE
3647
DELISTED
Zynerba Pharmaceuticals, Inc
ZYNE
$22K ﹤0.01%
+1,722
New +$19.7K
CCXI
3648
DELISTED
ChemoCentryx, Inc.
CCXI
$22K ﹤0.01%
+3,738
New +$25.6K
DOVA
3649
DELISTED
Dova Pharmaceuticals, Inc. Common Stock
DOVA
$22K ﹤0.01%
+756
New +$20.7K
AGCO icon
3650
AGCO
AGCO
$8.89B
$21K ﹤0.01%
+296
New +$21.1K

Similar funds

Parallax Volatility Advisers's Q4 2017 Portfolio in Review

As of Q4 2017, Parallax Volatility Advisers held 5,549 positions worth $73.6B, up 21% from $60.6B the previous quarter. Its ten largest holdings account for 63% of the portfolio.

Parallax Volatility Advisers's Q4 2017 filing shows 2,351 new, 689 increased, 564 reduced and 493 closed positions. Its largest new stake was iShares MSCI Japan ETF: 520,841 shares worth $31.2M. The largest sale was iShares MSCI EAFE ETF, an estimated $227M.

By sector, the portfolio is most concentrated in Miscellaneous at 96% of assets, down from 97% a quarter earlier, followed by Financials and Technology.

  • Parallax Volatility Advisers's largest Q4 2017 buy was iShares MSCI Japan ETF: 520,841 shares worth $31.2M.
  • Parallax Volatility Advisers added most to iShares Russell 2000 ETF in Q4 2017, an estimated $118M increase.
  • Parallax Volatility Advisers's biggest Q4 2017 reduction was iShares MSCI EAFE ETF, cutting an estimated $227M.
  • Parallax Volatility Advisers fully exited Berkshire Hathaway Class A in Q4 2017, selling an estimated $19.5M.
  • Parallax Volatility Advisers's ten largest holdings make up 63% of its $73.6B portfolio in Q4 2017.
  • Parallax Volatility Advisers opened 2,351 new positions and closed 493 in Q4 2017.
  • Parallax Volatility Advisers's portfolio value rose 21% quarter-over-quarter to $73.6B.

Based on Parallax Volatility Advisers's 13F filing for Q4 2017, filed 14 Feb 2018.